MYC and acute lymphoblastic leukemia: Recent studies have demonstrated that HHT can exert antitumor effects in T-ALL by inhibiting the NOTCH/MYC pathway, which has been shown to significantly prolong the survival of T-ALL mouse and patient-derived xenograft models [30].